HopeStage
Back to all studies
RecruitingNCT06795581

Brain PDE4B imaging in people with alcohol use disorder

About this titleRead the official source — NCT06795581
Medication studyAges 18–70United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 70 years.

Listed locations
BethesdaSee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: March 20, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
30
Sponsor
National Institute of Mental Health (NIMH)
Sponsor type
Government agency
Study type
Drug
Intervention type
Drug
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
From 18 Years to 70 Years
Official registry ID
NCT06795581
Official title
Show the full official title

PET Imaging of Phosphodiesterase-4B (PDE4B) in Alcohol Use Disorder

Recruitment & locations

Currently recruiting

Bethesda

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is National Institute of Mental Health (NIMH), a government agency.

Does this study involve medication?

Yes. The study involves medication, including 18F-PF-06445974 and Oxazepam.

Who can participate?

Listed age limits: 18 years to 70 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies